The past, present, and future of healthcare‐associated infection prevention in pediatrics: multidrug‐resistant organisms

Aaron M Milstone; Kristina A Bryant; W Charles Huskins; Danielle M Zerr

doi:10.1086/656001

The past, present, and future of healthcare‐associated infection prevention in pediatrics: multidrug‐resistant organisms

Infect Control Hosp Epidemiol. 2010 Nov:31 Suppl 1:S18-21. doi: 10.1086/656001.

Authors

Aaron M Milstone¹, Kristina A Bryant, W Charles Huskins, Danielle M Zerr

Affiliation

¹ Department of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, 200 North Wolfe Street, Baltimore, MD 21287, USA. amilsto1@jhmi.edu

PMID: 20929361
DOI: 10.1086/656001

Abstract

Multidrug resistant organisms (MDROs) and healthcare‐associated infections (HAIs) are associated with increased lengths of hospital stay, increased costs, and increased mortality. We explore the scope of MDRO HAIs in children, current MDRO HAI prevention practices and data to support these practices, and we propose research topics targeting MDRO HAI prevention in children.

MeSH terms

Biomedical Research
Cross Infection / drug therapy
Cross Infection / prevention & control*
Drug Resistance, Bacterial / drug effects
Drug Resistance, Multiple / drug effects*
Health Care Surveys
Hospitals, Pediatric*
Humans
Risk Management / methods